乱用薬物検査市場：成分、サンプルタイプ、エンドユーザー別-世界予測2025-2030年

乱用薬物検査市場は、2023年に17億4,000万米ドルと評価され、2024年には18億7,000万米ドルに達すると予測され、CAGR 7.28%で成長し、2030年には28億6,000万米ドルに達すると予測されています。

乱用薬物検査市場には、尿、血液、唾液、毛髪などの生体サンプル中の違法薬物や処方薬物の分析、検出、モニタリングが含まれます。この市場は、世界の薬物乱用問題の高まりによる薬物スクリーニングの需要増加によって定義され、職場、スポーツ、法執行環境における公共の安全への懸念や規制を下支えしています。乱用薬物検査の必要性は、コンプライアンスを確保し、薬物のない環境を促進し、薬物の誤用に関連するリスクを軽減するという重要な役割に起因しています。アプリケーションは、ヘルスケア、企業、教育機関、法医学分野、リハビリセンターなど様々な分野に及んでいます。業界の成長は、薬物中毒の蔓延の深刻化、政府の厳しい規制、検査方法の技術的進歩といった要因によってもたらされます。ラボオンチップ、リアルタイムモニタリング用ウェアラブル、AIベースの分析ツールなどのイノベーションは、市場プレーヤーにとって大きな可能性を秘めています。しかし、プライバシーの問題、高度な薬物検査機器の高コスト、地域による規制のばらつきなどの課題が成長を阻害する可能性があります。また、検査にまつわる汚名や偽陽性の可能性も大きな課題となっています。イノベーションを目指す企業にとって、費用対効果が高く、迅速で、侵襲性の低い検査ソリューションの開発に注力することは、大きなビジネスチャンスをもたらす可能性があります。質量分析計やバイオセンサーなどの次世代検査プラットフォームを使って精度と納期を向上させることも、成長の道を開く可能性があります。さらに、薬物乱用防止のための予測モデル開発のための研究機関との提携は、競争力をもたらす可能性があります。このような進歩にもかかわらず、技術革新と個人情報の保護など倫理的配慮のバランスを保つことは依然として重要です。市場は激しい競合を特徴とし、より個別化された検査戦略へとシフトしているため、持続的な成長と市場浸透を目指す企業にとって、ダイナミックでありながら課題的な情勢となっています。

市場力学：急速に進化する乱用薬物検査市場の主要市場インサイトを公開

乱用薬物検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 薬物乱用治療に対する需要の高まり
  • アルコール・薬物検査を義務付ける厳しい法律
  • 薬物関連死亡率の増加と政府の取り組み
• 市場抑制要因
  • 一部の国では薬物検査はプライバシー権の侵害と認識されている
• 市場機会
  • 革新的でユーザーフレンドリーな使い捨て製品のイントロダクション
  • 薬物検査技術の進歩
• 市場の課題
  • 偽陽性の可能性

ポーターの5つの力：乱用薬物検査市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：乱用薬物検査市場における外部からの影響の把握

外部マクロ環境要因は、乱用薬物検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析乱用薬物検査市場における競合情勢の把握

乱用薬物検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス乱用薬物検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、乱用薬物検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨乱用薬物検査市場における成功への道筋を描く

乱用薬物検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 薬物乱用治療の需要増加
    • アルコールと薬物の検査を義務付ける厳しい法律
    • 薬物関連死亡率の上昇と政府の取り組み
  • 抑制要因
    • 一部の国では薬物検査はプライバシー権の侵害とみなされている
  • 機会
    • 革新的で使いやすい使い捨て製品のイントロダクション
    • 薬物検査における技術的進歩
  • 課題
    • 偽陽性検査の可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 乱用薬物検査市場：コンポーネント別

• アナライザー
• 消耗品
• ラボサービス
• 迅速検査装置

第7章 乱用薬物検査市場サンプルタイプ別

• 血
• 髪
• 経口補水液
• 汗
• 尿

第8章 乱用薬物検査市場：エンドユーザー別

• 刑事司法制度と法執行機関
• 病院
• 調査室
• 職場と学校

第9章 南北アメリカの乱用薬物検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の乱用薬物検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの乱用薬物検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Clinical Reference Laboratory, Inc.
• Danaher Corporation
• Drgerwerk AG & Co. KGaA
• Express Diagnostics International
• F. Hoffmann-La Roche Ltd
• GE Healthcare Inc.
• Laboratory Corporation of America Holdings
• Legacy Healthcare Services, Inc.
• Mayo Collaborative Services, Inc.
• Merck KGaA
• Pfizer Inc.
• Precision Diagnostic Services Inc
• Psychemedics Corporation
• Quest Diagnostics
• Sanofi SA
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc

LIST OF FIGURES

• FIGURE 1. DRUG OF ABUSE TESTING MARKET RESEARCH PROCESS
• FIGURE 2. DRUG OF ABUSE TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DRUG OF ABUSE TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DRUG OF ABUSE TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE & SCHOOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 34. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 51. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 52. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 54. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 106. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 107. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. POLAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 118. POLAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 119. POLAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 121. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 122. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Drug of Abuse Testing Market was valued at USD 1.74 billion in 2023, expected to reach USD 1.87 billion in 2024, and is projected to grow at a CAGR of 7.28%, to USD 2.86 billion by 2030.

The scope of the Drug of Abuse Testing market encompasses the analysis, detection, and monitoring of illegal or prescription drugs in biological samples such as urine, blood, saliva, and hair. This market is defined by the increasing demand for drug screening due to rising substance abuse issues worldwide, underpinning public safety concerns and regulations in workplace, sports, and law enforcement settings. The necessity for drug of abuse testing stems from its critical role in ensuring compliance, promoting a drug-free environment, and mitigating the risks associated with drug misuse. Applications span various sectors including healthcare, corporate, educational institutions, forensic sector, and rehabilitation centers. The industry's growth is driven by factors such as the escalating prevalence of drug addiction, stringent government regulations, and technological advancements in testing methods. Innovations like lab-on-chip, wearables for real-time monitoring, and AI-based analytic tools hold significant potential for market players. However, challenges such as privacy concerns, high costs of advanced drug testing equipment, and variability in regulations across regions can impede growth. Also, the stigma associated with testing and the potential for false-positive results pose significant challenges. For companies aiming at innovation, focusing on developing cost-effective, rapid, and less invasive testing solutions could yield substantial opportunities. Enhancing accuracy and turnaround time using next-generation testing platforms like mass spectrometry and biosensors can also present growth avenues. Furthermore, collaborations with research institutions for developing predictive models for drug abuse prevention can provide a competitive edge. Despite these advancements, maintaining the balance between technological innovation and ethical considerations, such as safeguarding personal data, remains crucial. The market is characterized by intense competition and is shifting towards more personalized testing strategies, creating a dynamic yet challenging landscape for businesses aiming at sustainable growth and market penetration.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug of Abuse Testing Market

The Drug of Abuse Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing demand for drug abuse treatment
  • Stringent law mandating alcohol and drug testing
  • Increasing drug-related mortality rate and government initiative
• Market Restraints
  • Drug testing is recognized as a violation of privacy rights in some countries
• Market Opportunities
  • Introduction to innovative and user-friendly disposable products
  • Technological advancements in drug testing
• Market Challenges
  • Possibilities of false-positive test

Porter's Five Forces: A Strategic Tool for Navigating the Drug of Abuse Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug of Abuse Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug of Abuse Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug of Abuse Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug of Abuse Testing Market

A detailed market share analysis in the Drug of Abuse Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug of Abuse Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug of Abuse Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug of Abuse Testing Market

A strategic analysis of the Drug of Abuse Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug of Abuse Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Danaher Corporation, Drgerwerk AG & Co. KGaA, Express Diagnostics International, F. Hoffmann-La Roche Ltd, GE Healthcare Inc., Laboratory Corporation of America Holdings, Legacy Healthcare Services, Inc., Mayo Collaborative Services, Inc., Merck KGaA, Pfizer Inc., Precision Diagnostic Services Inc, Psychemedics Corporation, Quest Diagnostics, Sanofi SA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Drug of Abuse Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across Analyzers, Consumables, Laboratory Services, and Rapid Testing Devices.
• Based on Sample Type, market is studied across Blood, Hair, Oral Fluids, Sweat, and Urine.
• Based on End User, market is studied across Criminal Justice Systems & Law Enforcement Agencies, Hospitals, Research Laboratories, and Workplace & School.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand for drug abuse treatment
    • 5.1.1.2. Stringent law mandating alcohol and drug testing
    • 5.1.1.3. Increasing drug-related mortality rate and government initiative
  • 5.1.2. Restraints
    • 5.1.2.1. Drug testing is recognized as a violation of privacy rights in some countries
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction to innovative and user-friendly disposable products
    • 5.1.3.2. Technological advancements in drug testing
  • 5.1.4. Challenges
    • 5.1.4.1. Possibilities of false-positive test
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug of Abuse Testing Market, by Component

• 6.1. Introduction
• 6.2. Analyzers
• 6.3. Consumables
• 6.4. Laboratory Services
• 6.5. Rapid Testing Devices

7. Drug of Abuse Testing Market, by Sample Type

• 7.1. Introduction
• 7.2. Blood
• 7.3. Hair
• 7.4. Oral Fluids
• 7.5. Sweat
• 7.6. Urine

8. Drug of Abuse Testing Market, by End User

• 8.1. Introduction
• 8.2. Criminal Justice Systems & Law Enforcement Agencies
• 8.3. Hospitals
• 8.4. Research Laboratories
• 8.5. Workplace & School

9. Americas Drug of Abuse Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Drug of Abuse Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Drug of Abuse Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Bio-Rad Laboratories, Inc.
• 3. Clinical Reference Laboratory, Inc.
• 4. Danaher Corporation
• 5. Drgerwerk AG & Co. KGaA
• 6. Express Diagnostics International
• 7. F. Hoffmann-La Roche Ltd
• 8. GE Healthcare Inc.
• 9. Laboratory Corporation of America Holdings
• 10. Legacy Healthcare Services, Inc.
• 11. Mayo Collaborative Services, Inc.
• 12. Merck KGaA
• 13. Pfizer Inc.
• 14. Precision Diagnostic Services Inc
• 15. Psychemedics Corporation
• 16. Quest Diagnostics
• 17. Sanofi SA
• 18. Siemens Healthineers AG
• 19. Thermo Fisher Scientific Inc